Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2012

Aug 15, 2012

35106_dirs_2012-08-15_2a7c7125-7a2f-42e8-9f1c-e7cb5e808883.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-08-13

Reporting Person: Kornberg Joshua (Director, CEO and President, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-13 Non-qualified Stock Options $0.08 A 6000000 Acquired 2022-08-13 Common Stock, par value $0.01 per share (6000000) Direct

Footnotes

F1: The grant of non-qualified stock options to Mr. Kornberg was made pursuant to his Employment Agreement, dated as of August 13, 2012, with BioDrain Medical, Inc. and was made in consideration of his entering into such Employment Agreement.